Epigallocatechin gallate (EGCG) is an antioxidant and anti-inflammatory natural active ingredient, and fewer studies have been conducted on the antioxidant and anti-inflammatory effects of EGCG in DKD and the regulatory mechanisms. This study investigated the effect and mechanism of EGCG on diabetic kidney damage in non-obese GK rats with idiopathic T2DM. Two different doses of EGCG (10 mg·kg-1 and 120 mg·kg-1) were administered to GK rats for 4 weeks. The body weight and daily food intake of rats were monitored during the experiment. At the end of the experiment, the serum and kidney tissues were collected to detect some kidney biochemical and pathological indicators and Nrf2-Keap1/MAPK signaling pathway related gene expression levels. The results show that EGCG could improve the kidney morphology and significantly increase the activities of antioxidant enzymes (such as SOD, CAT and GSH-Px), and inhibit the release of proinflammatory cytokines (MCP-1, IL-1β). In addition, EGCG could restrain oxidant stress by up-regulate the expression level of Nrf2 and inhibit inflammation by down-regulating the expression levels of JNK, NF-κB and P38 genes in kidney. The improvement effect of high dose was better than that of low dose in the experimental range. In conclusion, these results indicate that EGCG could ameliorate kidney injury caused by diabetes, and its mechanism might be related to anti-oxidative stress mediated by Nrf2-Keap1/MAPK signaling pathways.
PENG Liyuan
,
ZENG Hongzhe
,
WAN Liwei
,
WEN Shuai
,
LIU Changwei
,
AN Qin
,
BAO Sudu
,
HUANG Jian'an
,
LIU Zhonghua
. The Investigation of the Ameliorate Effect and Mechanism of EGCG on Non-obese GK Rat with Diabetic Kidney Damage[J]. Journal of Tea Science, 2023
, 43(6)
: 784
-794
.
DOI: 10.13305/j.cnki.jts.2023.06.003
[1] 李长平. 慢性肾脏病患者如何科学摄取营养[J]. 保健医苑, 2019(3): 16-17.
Li C P.How does patients with chronic kidney disease take nutrition scientifically[J]. Health Care, 2019(3): 16-17.
[2] Ruiz-Ortega M, Rodrigues-Diez R R, Lavoz C, et al. Special issue "diabetic nephropathy: diagnosis, prevention and treatment"[J]. Journal of Clinical Medicine, 2020, 9(3): 813. doi: doi.org/10.3390/jcm9030813.
[3] Ross S A.Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes[J]. The American Journal of Medicine, 2013, 126(9s1): S38-S48.
[4] Wan C P, Ouyang J, Li M X, et al.Effects of green tea polyphenol extract and epigallocatechin-3-O-gallate on diabetes mellitus and diabetic complications: recent advances [J/OL]. Critical Reviews in Food Science and Nutrition, 2022: 1-29. doi: 10.1080/10408398.2022.2157372.
[5] 尹昀东, 方朝晖, 尤良震. GK大鼠生物学特性及其在糖尿病相关模型制备中应用的研究进展[J]. 山东医药, 2018, 58(46): 86-89.
Yin Y D, Fang Z H, You L Z.Research progress on biological characteristics of GK rats and its application in the preparation of diabetes-related models[J]. Shandong Medical Journal, 2018, 58(46): 86-89.
[6] Kojima N, Slaughter T N, Paige A, et al.Comparison of the development diabetic induced renal disease in strains of Goto-Kakizaki rats[J]. Journal of Diabetes & Metabolism, 2013, 37(s9): 5. doi: 10.4172/2155-6156.S9-005.
[7] Zhang Z T, Guo N, Zhuang G D, et al.Metabolic profiling of carbonyl compounds for unveiling protective mechanisms of Pueraria lobata against diabetic nephropathy by UPLC-Q-Orbitrap HRMS/MS analysis[J]. Journal of Agricultural and Food Chemistry, 2021, 69(37): 10943-10951.
[8] Yang Z, Zhu M Z, Zhang Y B, et al.Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats[J]. Phytotherapy Research, 2019, 33(4): 1019-1026.
[9] 文馨月, 唐雪阳, 何丹, 等. 中药调节肠道菌群与代谢产物改善高尿酸血症研究进展[J]. 中国中药杂志, 2021, 46(24): 6387-6394.
Wen X Y, Tang X Y, He D, et al.Research progress on anti-hyperuricemia effects and mechanisms of Chinese medicines based on regulation of intestinal flora and metabolites[J]. China Journal of Chinese Materia Medica, 2021, 46(24): 6387-6394.
[10] 郭立新. 2021年糖尿病领域年度重大进展回顾[J]. 中华糖尿病杂志, 2022, 14(1): 1-8.
Guo L X.2021 annual review of major progress in diabetes[J]. Chinese Journal of Diabetes Mellitus, 2022, 14(1): 1-8.
[11] Zhang X X, Kong J, Yun K.Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a meta-analysis of observational studies[J]. Journal of Diabetes Research, 2020, 2020: 2315607. doi: 10.1155/2020/2315607.
[12] 中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304.
Chinese Society of Nephrology Expert Group. Chinese guidelines for diagnosis and treatment of diabetic kidney disease[J]. Chinese Journal of Nephrology, 2021, 37(3): 255-304.
[13] Fioretto P, Mauer M.Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification[J]. Nature Reviews Nephrology, 2010, 6(9): 508-510.
[14] Xia X Y, Wang X D, Wang H, et al.Ameliorative effect of white tea from 50-year-old tree of Camellia sinensis L. (Theaceae) on kidney damage in diabetic mice via SIRT1/AMPK pathway[J]. Journal of Ethnopharmacology, 2021, 272: 113919. doi: 10.1016/j.jep.2021.113919.
[15] Tanase D M, Gosav E M, Anton M I, et al.Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): new perspectives[J]. Biomolecules, 2022, 12(9): 1227. doi: 10.3390/biom12091227.
[16] Cao T, Zhang X, Yang D, et al.Antioxidant effects of epigallocatechin-3-gallate on the aTC1-6 pancreatic alpha cell line[J]. Biochemical and Biophysical Research Communications, 2018, 495(1): 693-699.
[17] Coyle C H, Philips B J, Morrisroe S N, et al.Antioxidant effects of green tea and its polyphenols on bladder cells[J]. Life Sciences, 2008, 83(1/2): 12-18.
[18] Yan J, Feng Z H, Liu J, et al.Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate[J]. The Journal of Nutritional Biochemistry, 2012, 23(7): 716-724.
[19] Surh Y J, Kundu J K, Na H K.Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals[J]. Planta Medica, 2008, 74(13): 1526-1539.
[20] Wang D X, Wang Y J, Wan X C, et al.Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway[J]. Toxicology and Applied Pharmacology, 2015, 283(1): 65-74.
[21] Khan M A, Tania M, Zhang D Z, et al.Antioxidant enzymes and cancer[J]. Chinese Journal of Cancer Research, 2010, 22(2): 87-92.
[22] Na H K, Surh Y J.Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG[J]. Food and Chemical Toxicology, 2008, 46(4): 1271-1278.
[23] Ginn-Pease M E, Whisler R L. Redox signals and NF-kappaB activation in T cells[J]. Free Radical Biology &Medicine, 1998, 25(3): 346-361.
[24] 周继红, 陈蔚, 丁乐佳, 等. EGCG改善高果糖饮食小鼠代谢紊乱的作用与机制研究[J]. 茶叶科学, 2023, 43(3): 399-410.
Zhou J H, Chen W, Ding L J, et al.Regulatory effect and mechanism of EGCG on metabolic disorders in high-fructose diet mice[J]. Journal of Tea Science, 2023, 43(3): 399-410.
[25] Uchiyama Y, Suzuki T, Mochizuki K, et al.Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats[J]. Journal of Agricultural and Food Chemistry, 2013, 61(47): 11410-11417.
浙公网安备 33019902000101号 
